{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:00:14Z","timestamp":1780509614037,"version":"3.54.1"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00431-018-3144-8","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T06:29:30Z","timestamp":1525415370000},"page":"961-977","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Development of minimum standards of care for juvenile localized scleroderma"],"prefix":"10.1007","volume":"177","author":[{"given":"Tam\u00e1s","family":"Constantin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Foeldvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare E.","family":"Pain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annam\u00e1ria","family":"P\u00e1link\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"H\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Nemkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Weibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Laczkovszki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn S.","family":"Torok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"3144_CR1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jaad.2012.01.011","volume":"67","author":"W Johnson","year":"2012","unstructured":"Johnson W, Jacobe H (2012) Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment. J Am Acad Dermatol 67:881\u2013889","journal-title":"J Am Acad Dermatol"},{"key":"3144_CR2","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/j.1365-2133.2011.10600.x","volume":"165","author":"L Weibel","year":"2011","unstructured":"Weibel L, Laguda B, Atherton D, Harper JI (2011) Misdiagnosis and delay in referral of children with localized scleroderma. Br J Dermatol 165:1308\u20131313","journal-title":"Br J Dermatol"},{"key":"3144_CR3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.21687","volume":"64","author":"SC Li","year":"2012","unstructured":"Li SC, Torok KS, Pope E, Dedeoglu F, Hong S, Jacobe HT, Rabinovich CE, Laxer RM, Higgins GC, Ferguson PJ, Lasky A, Baszis K, Becker M, Campillo S, Cartwright V, Cidon M, Inman CJ, Jerath R, O'Neil KM, Vora S, Zeft A, Wallace CA, Ilowite NT, Fuhlbrigge RC (2012) Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res 64:1175\u20131185","journal-title":"Arthritis Care Res"},{"key":"3144_CR4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","volume":"45","author":"F Zulian","year":"2006","unstructured":"Zulian F, Athreya BH, Laxer R, Nelson AM, Feitosa de Oliveira SK, Punaro MG, Cuttica R, Higgins GC, Van Suijlekom-Smit LW, Moore TL, Lindsley C, Garcia-Consuegra J, Esteves Hilario MO, Lepore L, Silva CA, Machado C, Garay SM, Uziel Y, Martini G, Foeldvari I, Peserico A, Woo P, Harper J, Juvenile Scleroderma Working Group of the Pediatric Rheumatology European S (2006) Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford, England) 45:614\u2013620","journal-title":"Rheumatology (Oxford, England)"},{"key":"3144_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s11926-012-0308-9","volume":"15","author":"S Nouri","year":"2013","unstructured":"Nouri S, Jacobe H (2013) Recent developments in diagnosis and assessment of morphea. Curr Rheumatol Rep 15:308","journal-title":"Curr Rheumatol Rep"},{"key":"3144_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/acr.20070","volume":"62","author":"AL Herrick","year":"2010","unstructured":"Herrick AL, Ennis H, Bhushan M, Silman AJ, Baildam EM (2010) Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland. Arthritis Care Res 62:213\u2013218","journal-title":"Arthritis Care Res"},{"key":"3144_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00105-011-2199-5","volume":"63","author":"L Weibel","year":"2012","unstructured":"Weibel L (2012) Localized scleroderma (morphea) in childhood. Der Hautarzt; Zeitschrift Dermatol, Venerol Verwandte Geb 63:89\u201396","journal-title":"Der Hautarzt; Zeitschrift Dermatol, Venerol Verwandte Geb"},{"key":"3144_CR8","unstructured":"Kreuter A, Krieg T, Worm M, Wenzel J, Gambichler T, Kuhn A, Aberer E, Scharffetter-Kochanek K, Hunzelmann N (2009) AWMF guideline no. 013\/066. Diagnosis and therapy of circumscribed scleroderma. J Deutschen Dermatol Ges = J German Soc Dermatol: JDDG 7(Suppl 6):S1\u2013S14"},{"key":"3144_CR9","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.4065\/70.11.1068","volume":"70","author":"LS Peterson","year":"1995","unstructured":"Peterson LS, Nelson AM, Su WP (1995) Classification of morphea (localized scleroderma). Mayo Clin Proc 70:1068\u20131076","journal-title":"Mayo Clin Proc"},{"key":"3144_CR10","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/rheumatology\/ker521","volume":"51","author":"DP Hawley","year":"2012","unstructured":"Hawley DP, Baildam EM, Amin TS, Cruikshank MK, Davidson JE, Dixon J, Martin NS, Ohlsson V, Pilkington C, Rangaraj S, Riley P, Sundaramoorthy C, Walsh J, Foster HE (2012) Access to care for children and young people diagnosed with localized scleroderma or juvenile SSc in the UK. Rheumatology (Oxford, England) 51:1235\u20131239","journal-title":"Rheumatology (Oxford, England)"},{"key":"3144_CR11","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1093\/rheumatology\/keu212","volume":"53","author":"DP Hawley","year":"2014","unstructured":"Hawley DP, Pain CE, Baildam EM, Murphy R, Taylor AE, Foster HE (2014) United Kingdom survey of current management of juvenile localized scleroderma. Rheumatology (Oxford, England) 53:1849\u20131854","journal-title":"Rheumatology (Oxford, England)"},{"key":"3144_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3899\/jrheum.100447","volume":"38","author":"EM Baildam","year":"2011","unstructured":"Baildam EM, Ennis H, Foster HE, Shaw L, Chieng AS, Kelly J, Herrick AL, Richards HL (2011) Influence of childhood scleroderma on physical function and quality of life. J Rheumatol 38:167\u2013173","journal-title":"J Rheumatol"},{"key":"3144_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/rheumatology\/kep059","volume":"48","author":"NM Orzechowski","year":"2009","unstructured":"Orzechowski NM, Davis DM, Mason TG 3rd, Crowson CS, Reed AM (2009) Health-related quality of life in children and adolescents with juvenile localized scleroderma. Rheumatology (Oxford, England) 48:670\u2013672","journal-title":"Rheumatology (Oxford, England)"},{"key":"3144_CR14","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jaad.2013.11.037","volume":"70","author":"S Das","year":"2014","unstructured":"Das S, Bernstein I, Jacobe H (2014) Correlates of self-reported quality of life in adults and children with morphea. J Am Acad Dermatol 70:904\u2013910","journal-title":"J Am Acad Dermatol"},{"key":"3144_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/ddg.12724","volume":"14","author":"A Kreuter","year":"2016","unstructured":"Kreuter A, Krieg T, Worm M, Wenzel J, Moinzadeh P, Kuhn A, Aberer E, Scharffetter-Kochanek K, Horneff G, Reil E, Weberschock T, Hunzelmann N (2016) German guidelines for the diagnosis and therapy of localized scleroderma. J Deutschen Dermatol Ges = J German Soc Dermatol: JDDG 14:199\u2013216","journal-title":"J Deutschen Dermatol Ges = J German Soc Dermatol: JDDG"},{"key":"3144_CR16","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1136\/ard.2004.023697","volume":"63","author":"M Dougados","year":"2004","unstructured":"Dougados M, Betteridge N, Burmester GR, Euller-Ziegler L, Guillemin F, Hirvonen J, Lloyd J, Ozen S, Da Silva JA, Emery P, Kalden JR, Kvien T, Matucci-Cerinic M, Smolen J (2004) EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis 63:1172\u20131176","journal-title":"Ann Rheum Dis"},{"key":"3144_CR17","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1136\/ard.2006.055251","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Liote F, McCarthy G, Netter P, Nuki G, Perez-Ruiz F, Pignone A, Pimentao J, Punzi L, Roddy E, Uhlig T, Zimmermann-Gorska I (2006) EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1301\u20131311","journal-title":"Ann Rheum Dis"},{"key":"3144_CR18","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Liote F, McCarthy G, Netter P, Nuki G, Perez-Ruiz F, Pignone A, Pimentao J, Punzi L, Roddy E, Uhlig T, Zimmermann-Gorska I (2006) EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1312\u20131324","journal-title":"Ann Rheum Dis"},{"key":"3144_CR19","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/bjd.12606","volume":"169","author":"M Piram","year":"2013","unstructured":"Piram M, McCuaig CC, Saint-Cyr C, Marcoux D, Hatami A, Haddad E, Powell J (2013) Short- and long-term outcome of linear morphoea in children. Br J Dermatol 169:1265\u20131271","journal-title":"Br J Dermatol"},{"key":"3144_CR20","unstructured":"Blaszczyk M, Janniger CK, Jablonska S (1996) Childhood scleroderma and its peculiarities. Cutis 58:141\u2013144, 148\u2013152"},{"key":"3144_CR21","unstructured":"(2009) Weedon\u2019s skin pathology. Churchill Livingstone"},{"key":"3144_CR22","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jaad.2010.08.027","volume":"65","author":"X Wortsman","year":"2011","unstructured":"Wortsman X, Wortsman J, Sazunic I, Carreno L (2011) Activity assessment in morphea using color Doppler ultrasound. J Am Acad Dermatol 65:942\u2013948","journal-title":"J Am Acad Dermatol"},{"key":"3144_CR23","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1525-1470.2010.01258.x","volume":"27","author":"M Beltramelli","year":"2010","unstructured":"Beltramelli M, Vercellesi P, Frasin A, Gelmetti C, Corona F (2010) Localized severe scleroderma: a retrospective study of 26 pediatric patients. Pediatr Dermatol 27:476\u2013480","journal-title":"Pediatr Dermatol"},{"key":"3144_CR24","doi-asserted-by":"crossref","unstructured":"Herrick AL, Ennis H, Bhushan M, Silman AJ, Baildam EM Clinical features of childhood localized scleroderma in an incidence cohort. Rheumatology (Oxford, England) 50:1865\u20131868","DOI":"10.1093\/rheumatology\/ker142"},{"issue":"Suppl 11","key":"3144_CR25","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1002\/art.38444","volume":"66","author":"EY Wu","year":"2014","unstructured":"Wu EY, Li SC, Torok KS, Virkud Y, Fuhlbrigge R, Rabinovich CE (2014) A28: Description of the Juvenile Localized Scleroderma Subgroup of the CARRA Registry. Arthritis Rheumatol (Hoboken, NJ) 66(Suppl 11):S43\u2013S44","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"3144_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/0049-0172(94)90028-0","volume":"23","author":"Y Uziel","year":"1994","unstructured":"Uziel Y, Krafchik BR, Silverman ED, Thorner PS, Laxer RM (1994) Localized scleroderma in childhood: a report of 30 cases. Semin Arthritis Rheum 23:328\u2013340","journal-title":"Semin Arthritis Rheum"},{"key":"3144_CR27","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/art.1780390624","volume":"39","author":"R Vancheeswaran","year":"1996","unstructured":"Vancheeswaran R, Black CM, David J, Hasson N, Harper J, Atherton D, Trivedi P, Woo P (1996) Childhood-onset scleroderma: is it different from adult-onset disease. Arthritis Rheum 39:1041\u20131049","journal-title":"Arthritis Rheum"},{"key":"3144_CR28","first-page":"171","volume":"13","author":"AV Marzano","year":"2003","unstructured":"Marzano AV, Menni S, Parodi A, Borghi A, Fuligni A, Fabbri P, Caputo R (2003) Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Europ J Dermatol: EJD 13:171\u2013176","journal-title":"Europ J Dermatol: EJD"},{"key":"3144_CR29","first-page":"2337","volume":"22","author":"AM Rosenberg","year":"1995","unstructured":"Rosenberg AM, Uziel Y, Krafchik BR, Hauta SA, Prokopchuk PA, Silverman ED, Laxer RM (1995) Antinuclear antibodies in children with localized scleroderma. J Rheumatol 22:2337\u20132343","journal-title":"J Rheumatol"},{"key":"3144_CR30","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/art.1780260506","volume":"26","author":"K Takehara","year":"1983","unstructured":"Takehara K, Moroi Y, Nakabayashi Y, Ishibashi Y (1983) Antinuclear antibodies in localized scleroderma. Arthritis Rheum 26:612\u2013616","journal-title":"Arthritis Rheum"},{"key":"3144_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","volume":"59","author":"S Christen-Zaech","year":"2008","unstructured":"Christen-Zaech S, Hakim MD, Afsar FS, Paller AS (2008) Pediatric morphea (localized scleroderma): review of 136 patients. J Am Acad Dermatol 59:385\u2013396","journal-title":"J Am Acad Dermatol"},{"key":"3144_CR32","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","volume":"18","author":"RM Laxer","year":"2006","unstructured":"Laxer RM, Zulian F (2006) Localized scleroderma. Curr Opin Rheumatol 18:606\u2013613","journal-title":"Curr Opin Rheumatol"},{"key":"3144_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/rheumatology\/keh487","volume":"44","author":"K Takehara","year":"2005","unstructured":"Takehara K, Sato S (2005) Localized scleroderma is an autoimmune disorder. Rheumatology (Oxford, England) 44:274\u2013279","journal-title":"Rheumatology (Oxford, England)"},{"key":"3144_CR34","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0190-9622(94)70217-9","volume":"31","author":"S Sato","year":"1994","unstructured":"Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K (1994) Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. J Am Acad Dermatol 31:567\u2013571","journal-title":"J Am Acad Dermatol"},{"key":"3144_CR35","unstructured":"Lo CY, Shyur SD, Chu SH, Huang LH, Kao YH, Lei WT, Cheng CH, Lee KH, Chen CK, Liu LC Juvenile scleroderma: experience in one institution. Asian Pac J Allergy Immunol\/ Launched Allergy Immunol Soc Thailand 28:279\u2013286"},{"key":"3144_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000246474","volume":"191","author":"A Parodi","year":"1995","unstructured":"Parodi A, Drosera M, Barbieri L, Rebora A (1995) Antihistone antibodies in scleroderma. Dermatology (Basel, Switzerland) 191:16\u201318","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"3144_CR37","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/j.1365-4632.2006.02891.x","volume":"45","author":"RA el-Azhary","year":"2006","unstructured":"el-Azhary RA, Aponte CC, Nelson AM, Weaver AL, Homburger HA (2006) Antihistone antibodies in linear scleroderma variants. Int J Dermatol 45:1296\u20131299","journal-title":"Int J Dermatol"},{"key":"3144_CR38","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/jamadermatol.2013.4207","volume":"149","author":"JW Dharamsi","year":"2013","unstructured":"Dharamsi JW, Victor S, Aguwa N, Ahn C, Arnett F, Mayes MD, Jacobe H (2013) Morphea in adults and children cohort III: nested case-control study\u2014the clinical significance of autoantibodies in morphea. JAMA dermatology 149:1159\u20131165","journal-title":"JAMA dermatology"},{"key":"3144_CR39","doi-asserted-by":"publisher","first-page":"849","DOI":"10.7326\/0003-4819-104-6-849","volume":"104","author":"V Falanga","year":"1986","unstructured":"Falanga V, Medsger TA Jr, Reichlin M, Rodnan GP (1986) Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med 104:849\u2013857","journal-title":"Ann Intern Med"},{"key":"3144_CR40","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.3899\/jrheum.080098","volume":"35","author":"T Arkachaisri","year":"2008","unstructured":"Arkachaisri T, Fertig N, Pino S, Medsger TA Jr (2008) Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study. J Rheumatol 35:2439\u20132444","journal-title":"J Rheumatol"},{"key":"3144_CR41","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jaad.2009.05.022","volume":"61","author":"K Weber","year":"2009","unstructured":"Weber K (2009) Is juvenile localized scleroderma related to Lyme borreliosis? J Am Acad Dermatol 61:901","journal-title":"J Am Acad Dermatol"},{"key":"3144_CR42","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1046\/j.1365-2133.2000.03407.x","volume":"142","author":"B Weide","year":"2000","unstructured":"Weide B, Walz T, Garbe C (2000) Is morphoea caused by Borrelia burgdorferi? A review. Br J Dermatol 142:636\u2013644","journal-title":"Br J Dermatol"},{"key":"3144_CR43","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/0190-9622(95)91311-4","volume":"33","author":"W Fan","year":"1995","unstructured":"Fan W, Leonardi CL, Penneys NS (1995) Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea). J Am Acad Dermatol 33:682\u2013684","journal-title":"J Am Acad Dermatol"},{"key":"3144_CR44","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/0190-9622(95)91281-9","volume":"33","author":"WI Dillon","year":"1995","unstructured":"Dillon WI, Saed GM, Fivenson DP (1995) Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J Am Acad Dermatol 33:617\u2013620","journal-title":"J Am Acad Dermatol"},{"key":"3144_CR45","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1365-2133.1992.tb00117.x","volume":"127","author":"G Raguin","year":"1992","unstructured":"Raguin G, Boisnic S, Souteyrand P, Baranton G, Piette JC, Godeau P, Frances C (1992) No evidence for a spirochaetal origin of localized scleroderma. Br J Dermatol 127:218\u2013220","journal-title":"Br J Dermatol"},{"key":"3144_CR46","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000247569","volume":"184","author":"L Vaillant","year":"1992","unstructured":"Vaillant L, Goudeau A (1992) Localized scleroderma is not a Borrelia burgdorferi infection in France. Dermatology (Basel, Switzerland) 184:286\u2013288","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"3144_CR47","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/rheumatology\/30.2.154","volume":"30","author":"S Lupoli","year":"1991","unstructured":"Lupoli S, Cutler SJ, Stephens CO, Wright DJ, Black CM (1991) Lyme disease and localized scleroderma\u2014no evidence for a common aetiology. Br J Rheumatol 30:154\u2013156","journal-title":"Br J Rheumatol"},{"key":"3144_CR48","first-page":"157","volume":"144","author":"K Eisendle","year":"2009","unstructured":"Eisendle K, Zelger B (2009) The expanding spectrum of cutaneous borreliosis. G Ital Dermatol Venereol 144:157\u2013171","journal-title":"G Ital Dermatol Venereol"},{"key":"3144_CR49","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1046\/j.1365-4362.2000.00912.x","volume":"39","author":"S Ozkan","year":"2000","unstructured":"Ozkan S, Atabey N, Fetil E, Erkizan V, Gunes AT (2000) Evidence for Borrelia burgdorferi in morphea and lichen sclerosus. Int J Dermatol 39:278\u2013283","journal-title":"Int J Dermatol"},{"key":"3144_CR50","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/1523-1747.ep12472369","volume":"100","author":"C Schempp","year":"1993","unstructured":"Schempp C, Bocklage H, Lange R, Kolmel HW, Orfanos CE, Gollnick H (1993) Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol 100:717\u2013720","journal-title":"J Invest Dermatol"},{"key":"3144_CR51","first-page":"573","volume":"23","author":"S Akimoto","year":"1996","unstructured":"Akimoto S, Ishikawa O, Miyachi Y (1996) The absence of antibodies against Borrelia burgdorferi in the sera of Japanese patients with localized scleroderma. J Rheumatol 23:573\u2013574","journal-title":"J Rheumatol"},{"key":"3144_CR52","first-page":"283","volume":"47","author":"F Espinoza-Leon","year":"2006","unstructured":"Espinoza-Leon F, Hassanhi-Hassanhi M, Arocha-Sandoval F, Urbina-Lopez M (2006) Absence of Borrelia burgdorferi antibodies in the sera of Venezuelan patients with localized scleroderma (morphea). Investig Clin 47:283\u2013288","journal-title":"Investig Clin"},{"key":"3144_CR53","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1600-0560.2009.01493.x","volume":"37","author":"T Zollinger","year":"2010","unstructured":"Zollinger T, Mertz KD, Schmid M, Schmitt A, Pfaltz M, Kempf W (2010) Borrelia in granuloma annulare, morphea and lichen sclerosus: a PCR-based study and review of the literature. J Cutan Pathol 37:571\u2013577","journal-title":"J Cutan Pathol"},{"key":"3144_CR54","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/mp.55.6.374","volume":"55","author":"JR Goodlad","year":"2002","unstructured":"Goodlad JR, Davidson MM, Gordon P, Billington R, Ho-Yen DO (2002) Morphoea and Borrelia burgdorferi: results from the Scottish highlands in the context of the world literature. Mol Pathol: MP 55:374\u2013378","journal-title":"Mol Pathol: MP"},{"key":"3144_CR55","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1046\/j.1365-2133.2000.03775.x","volume":"143","author":"B Weide","year":"2000","unstructured":"Weide B, Schittek B, Klyscz T, Schuz K, Stark M, Rassner G, Wilske B, Garbe C (2000) Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction. Br J Dermatol 143:780\u2013785","journal-title":"Br J Dermatol"},{"key":"3144_CR56","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/1523-1747.ep12613456","volume":"104","author":"R Wienecke","year":"1995","unstructured":"Wienecke R, Schlupen EM, Zochling N, Neubert U, Meurer M, Volkenandt M (1995) No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma. J Invest Dermatol 104:23\u201326","journal-title":"J Invest Dermatol"},{"key":"3144_CR57","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/1523-1747.ep12371793","volume":"102","author":"A Ranki","year":"1994","unstructured":"Ranki A, Aavik E, Peterson P, Schauman K, Nurmilaakso P (1994) Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions. J Invest Dermatol 102:339\u2013345","journal-title":"J Invest Dermatol"},{"key":"3144_CR58","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1002\/art.21264","volume":"52","author":"F Zulian","year":"2005","unstructured":"Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J, Espada G, Corona F, Mukamel M, Vesely R, Musiej-Nowakowska E, Chaitow J, Ros J, Apaz MT, Gerloni V, Mazur-Zielinska H, Nielsen S, Ullman S, Horneff G, Wouters C, Martini G, Cimaz R, Laxer R, Athreya BH, Juvenile Scleroderma Working Group of the Pediatric Rheumatology European S (2005) Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 52:2873\u20132881","journal-title":"Arthritis Rheum"},{"key":"3144_CR59","first-page":"2692","volume":"27","author":"P Weber","year":"2000","unstructured":"Weber P, Ganser G, Frosch M, Roth J, Hulskamp G, Zimmer KP (2000) Twenty-four hour intraesophageal pH monitoring in children and adolescents with scleroderma and mixed connective tissue disease. J Rheumatol 27:2692\u20132695","journal-title":"J Rheumatol"},{"key":"3144_CR60","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1001\/archpedi.154.2.150","volume":"154","author":"SP Nelson","year":"2000","unstructured":"Nelson SP, Chen EH, Syniar GM, Christoffel KK (2000) Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric practice-based survey. Pediatric Practice Res Group. Arch Pediatr Adolesc Med 154:150\u2013154","journal-title":"Pediatric Practice Res Group. Arch Pediatr Adolesc Med"},{"issue":"Suppl 3","key":"3144_CR61","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1542\/peds.2008-2233C","volume":"123","author":"LJ Akinbami","year":"2009","unstructured":"Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ (2009) Status of childhood asthma in the United States, 1980\u20132007. Pediatrics 123(Suppl 3):S131\u2013S145","journal-title":"Pediatrics"},{"key":"3144_CR62","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3899\/jrheum.080021","volume":"36","author":"J Wozniak","year":"2009","unstructured":"Wozniak J, Dabrowski R, Luczak D, Kwiatkowska M, Musiej-Nowakowska E, Kowalik I, Szwed H (2009) Evaluation of heart rhythm variability and arrhythmia in children with systemic and localized scleroderma. J Rheumatol 36:191\u2013196","journal-title":"J Rheumatol"},{"key":"3144_CR63","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3109\/03009742.2011.609489","volume":"41","author":"A Borowiec","year":"2011","unstructured":"Borowiec A, Dabrowski R, Wozniak J, Jasek S, Chwyczko T, Kowalik I, Musiej-Nowakowska E, Szwed H (2011) Cardiovascular assessment of asymptomatic patients with juvenile-onset localized and systemic scleroderma: 10 years prospective observation. Scand J Rheumatol 41:33\u201338","journal-title":"Scand J Rheumatol"},{"key":"3144_CR64","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2340\/00015555-0645","volume":"89","author":"M Hayashi","year":"2009","unstructured":"Hayashi M, Ichiki Y, Kitajima Y (2009) Coexistence of recurrent generalized morphea and systemic sclerosis. Acta Derm Venereol 89:329\u2013330","journal-title":"Acta Derm Venereol"},{"key":"3144_CR65","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000246798","volume":"189","author":"H Holzmann","year":"1994","unstructured":"Holzmann H, Schlieter A (1994) Coexistence of morphea and systemic sclerosis. Dermatology (Basel, Switzerland) 189:99","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"3144_CR66","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000247317","volume":"186","author":"Y Soma","year":"1993","unstructured":"Soma Y, Tamaki T, Kikuchi K, Abe M, Igarashi A, Takehara K, Ishibashi Y (1993) Coexistence of morphea and systemic sclerosis. Dermatology (Basel, Switzerland) 186:103\u2013105","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"3144_CR67","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1001\/archderm.1992.01680150060005","volume":"128","author":"HR Maricq","year":"1992","unstructured":"Maricq HR (1992) Capillary abnormalities, Raynaud\u2019s phenomenon, and systemic sclerosis in patients with localized scleroderma. Arch Dermatol 128:630\u2013632","journal-title":"Arch Dermatol"},{"key":"3144_CR68","first-page":"131","volume":"9","author":"S Carneiro","year":"2011","unstructured":"Carneiro S, Ramos-e-Silva M, Russi DC, Albuquerque EM, Sousa MA (2011) Coexistence of generalized morphea and lichen sclerosus et atrophicus mimicking systemic disease. Skinmed 9:131\u2013133","journal-title":"Skinmed"},{"key":"3144_CR69","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1546-0096-9-18","volume":"9","author":"ET Fain","year":"2011","unstructured":"Fain ET, Mannion M, Pope E, Young DW, Laxer RM, Cron RQ, Brain cavernomas associated with en coup de sabre linear scleroderma (2011) Two case reports. Pediatr Rheumatol Online J 9:18","journal-title":"Pediatr Rheumatol Online J"},{"key":"3144_CR70","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1136\/bjo.2007.116038","volume":"91","author":"ME Zannin","year":"2007","unstructured":"Zannin ME, Martini G, Athreya BH, Russo R, Higgins G, Vittadello F, Alpigiani MG, Alessio M, Paradisi M, Woo P, Zulian F, Juvenile Scleroderma Working Group of the Pediatric Rheumatology European S (2007) Ocular involvement in children with localised scleroderma: a multi-centre study. Br J Ophthalmol 91:1311\u20131314","journal-title":"Br J Ophthalmol"},{"key":"3144_CR71","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1002\/art.22207","volume":"54","author":"G Martini","year":"2006","unstructured":"Martini G, Foeldvari I, Russo R, Cuttica R, Eberhard A, Ravelli A, Lehman TJ, de Oliveira SK, Susic G, Lyskina G, Nemcova D, Sundel R, Falcini F, Girschick H, Lotito AP, Buoncompagni A, Sztajnbok F, Al-Mayouf SM, Orban I, Ferri C, Athreya BH, Woo P, Zulian F, Juvenile Scleroderma Working Group of the Pediatric Rheumatology European S (2006) Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Arthritis Rheum 54:3971\u20133978","journal-title":"Arthritis Rheum"},{"key":"3144_CR72","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/sj.bdj.4804213","volume":"146","author":"TD Foster","year":"1979","unstructured":"Foster TD (1979) The effects of hemifacial atrophy on dental growth. Br Dent J 146:148\u2013150","journal-title":"Br Dent J"},{"key":"3144_CR73","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1097\/SCS.0b013e31820fe339","volume":"22","author":"KH You","year":"2011","unstructured":"You KH, Baik HS (2011) Orthopedic and orthodontic treatment of Parry\u2013Romberg syndrome. J Craniofac Surg 22:970\u2013973","journal-title":"J Craniofac Surg"},{"key":"3144_CR74","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0889-5406(86)90084-3","volume":"90","author":"PS Vig","year":"1986","unstructured":"Vig PS, Vig KW (1986) Hybrid appliances: a component approach to dentofacial orthopedics. Am J Orthod Dentofac Orthop 90:273\u2013285","journal-title":"Am J Orthod Dentofac Orthop"},{"key":"3144_CR75","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1597\/02-066","volume":"41","author":"C Grippaudo","year":"2004","unstructured":"Grippaudo C, Deli R, Grippaudo FR, Di Cuia T, Paradisi M (2004) Management of craniofacial development in the Parry\u2013Romberg syndrome: report of two patients. Cleft Palate Craniofac J 41:95\u2013104","journal-title":"Cleft Palate Craniofac J"},{"key":"3144_CR76","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3109\/02841850903271341","volume":"50","author":"N Tzaribachev","year":"2009","unstructured":"Tzaribachev N, Fritz J, Horger M (2009) Spectrum of magnetic resonance imaging appearances of juvenile temporomandibular joints (TMJ) in non-rheumatic children. Acta Radiologica (Stockholm, Sweden: 1987) 50:1182\u20131186","journal-title":"Acta Radiologica (Stockholm, Sweden: 1987)"},{"key":"3144_CR77","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12969-018-0223-3","volume":"16","author":"ML Stoll","year":"2018","unstructured":"Stoll ML, Guleria S, Mannion ML, Young DW, Royal SA, Cron RQ, Vaid YN (2018) Defining the normal appearance of the temporomandibular joints by magnetic resonance imaging with contrast: a comparative study of children with and without juvenile idiopathic arthritis. Pediatr Rheumatol Online J 16:8","journal-title":"Pediatr Rheumatol Online J"},{"key":"3144_CR78","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/rheumatology\/kel446","volume":"46","author":"F Zulian","year":"2007","unstructured":"Zulian F, Meneghesso D, Grisan E, Vittadello F, Belloni Fortina A, Pigozzi B, Frigo AC, Martini G, Ruggeri A (2007) A new computerized method for the assessment of skin lesions in localized scleroderma. Rheumatology (Oxford, England) 46:856\u2013860","journal-title":"Rheumatology (Oxford, England)"},{"key":"3144_CR79","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/bjd.14103","volume":"174","author":"S Poff","year":"2016","unstructured":"Poff S, Li SC, Kelsey CE, Foeldvari I, Torok KS (2016) Durometry as an outcome measure in juvenile localized scleroderma. Br J Dermatol 174:228\u2013230","journal-title":"Br J Dermatol"},{"key":"3144_CR80","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11926-009-0028-y","volume":"11","author":"SC Li","year":"2009","unstructured":"Li SC, Liebling MS (2009) The use of Doppler ultrasound to evaluate lesions of localized scleroderma. Curr Rheumatol Rep 11:205\u2013211","journal-title":"Curr Rheumatol Rep"},{"key":"3144_CR81","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/rheumatology\/kem120","volume":"46","author":"SC Li","year":"2007","unstructured":"Li SC, Liebling MS, Haines KA (2007) Ultrasonography is a sensitive tool for monitoring localized scleroderma. Rheumatology (Oxford, England) 46:1316\u20131319","journal-title":"Rheumatology (Oxford, England)"},{"key":"3144_CR82","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/acr.20407","volume":"63","author":"SC Li","year":"2011","unstructured":"Li SC, Liebling MS, Haines KA, Weiss JE, Prann A (2011) Initial evaluation of an ultrasound measure for assessing the activity of skin lesions in juvenile localized scleroderma. Arthritis Care Res 63:735\u2013742","journal-title":"Arthritis Care Res"},{"key":"3144_CR83","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1002\/art.22920","volume":"56","author":"L Weibel","year":"2007","unstructured":"Weibel L, Howell KJ, Visentin MT, Rudiger A, Denton CP, Zulian F, Woo P, Harper JI (2007) Laser Doppler flowmetry for assessing localized scleroderma in children. Arthritis Rheum 56:3489\u20133495","journal-title":"Arthritis Rheum"},{"key":"3144_CR84","first-page":"198","volume":"25","author":"M Boers","year":"1998","unstructured":"Boers M, Brooks P, Strand CV, Tugwell P (1998) The OMERACT filter for outcome measures in rheumatology. J Rheumatol 25:198\u2013199","journal-title":"J Rheumatol"},{"key":"3144_CR85","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0190-9622(98)70077-5","volume":"39","author":"BB Cunningham","year":"1998","unstructured":"Cunningham BB, Landells ID, Langman C, Sailer DE, Paller AS (1998) Topical calcipotriene for morphea\/linear scleroderma. J Am Acad Dermatol 39:211\u2013215","journal-title":"J Am Acad Dermatol"},{"key":"3144_CR86","first-page":"1271","volume":"22","author":"JE Pope","year":"1995","unstructured":"Pope JE, Baron M, Bellamy N, Campbell J, Carette S, Chalmers I, Dales P, Hanly J, Kaminska EA, Lee P et al (1995) Variability of skin scores and clinical measurements in scleroderma. J Rheumatol 22:1271\u20131276","journal-title":"J Rheumatol"},{"key":"3144_CR87","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.3899\/jrheum.081284","volume":"36","author":"T Arkachaisri","year":"2009","unstructured":"Arkachaisri T, Vilaiyuk S, Li S, O'Neil KM, Pope E, Higgins GC, Punaro M, Rabinovich EC, Rosenkranz M, Kietz DA, Rosen P, Spalding SJ, Hennon TR, Torok KS, Cassidy E, Medsger TA Jr, Localized Scleroderma C, Ultrasound Study G (2009) The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures. J Rheumatol 36:2819\u20132829","journal-title":"J Rheumatol"},{"key":"3144_CR88","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3899\/jrheum.110210","volume":"39","author":"KS Torok","year":"2012","unstructured":"Torok KS, Arkachaisri T (2012) Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study. J Rheumatol 39:286\u2013294","journal-title":"J Rheumatol"},{"key":"3144_CR89","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jaad.2013.02.007","volume":"69","author":"CE Kelsey","year":"2013","unstructured":"Kelsey CE, Torok KS (2013) The localized scleroderma cutaneous assessment tool: responsiveness to change in a pediatric clinical population. J Am Acad Dermatol 69:214\u2013220","journal-title":"J Am Acad Dermatol"},{"key":"3144_CR90","doi-asserted-by":"crossref","unstructured":"Arkachaisri T, Vilaiyuk S, Torok KS, Medsger TA Jr Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study. Rheumatology (Oxford, England) 49:373\u2013381","DOI":"10.1093\/rheumatology\/kep361"},{"key":"3144_CR91","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1365-2133.1995.tb16953.x","volume":"132","author":"MS Lewis-Jones","year":"1995","unstructured":"Lewis-Jones MS, Finlay AY (1995) The Children\u2019s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 132:942\u2013949","journal-title":"Br J Dermatol"},{"key":"3144_CR92","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3899\/jrheum.090708","volume":"37","author":"SC Li","year":"2010","unstructured":"Li SC, Feldman BM, Higgins GC, Haines KA, Punaro MG, O'Neil KM (2010) Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists. J Rheumatol 37:175\u2013181","journal-title":"J Rheumatol"},{"key":"3144_CR93","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1046\/j.1525-1470.2001.018003241.x","volume":"18","author":"A Kreuter","year":"2001","unstructured":"Kreuter A, Gambichler T, Avermaete A, Jansen T, Hoffmann M, Hoffmann K, Altmeyer P, von Kobyletzki G, Bacharach-Buhles M (2001) Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea. Pediatr Dermatol 18:241\u2013245","journal-title":"Pediatr Dermatol"},{"key":"3144_CR94","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jaad.2010.09.006","volume":"65","author":"BA Zwischenberger","year":"2011","unstructured":"Zwischenberger BA, Jacobe HT (2011) A systematic review of morphea treatments and therapeutic algorithm. J Am Acad Dermatol 65:925\u2013941","journal-title":"J Am Acad Dermatol"},{"key":"3144_CR95","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2133.2007.07971.x","volume":"157","author":"MT Dytoc","year":"2007","unstructured":"Dytoc MT, Kossintseva I, Ting PT (2007) First case series on the use of calcipotriol-betamethasone dipropionate for morphoea. Br J Dermatol 157:615\u2013618","journal-title":"Br J Dermatol"},{"key":"3144_CR96","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1365-2133.2004.06318.x","volume":"152","author":"G Mancuso","year":"2005","unstructured":"Mancuso G, Berdondini RM (2005) Localized scleroderma: response to occlusive treatment with tacrolimus ointment. Br J Dermatol 152:180\u2013182","journal-title":"Br J Dermatol"},{"key":"3144_CR97","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1365-2133.2005.06776.x","volume":"153","author":"M Dytoc","year":"2005","unstructured":"Dytoc M, Ting PT, Man J, Sawyer D, Fiorillo L (2005) First case series on the use of imiquimod for morphoea. Br J Dermatol 153:815\u2013820","journal-title":"Br J Dermatol"},{"key":"3144_CR98","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1159\/000335560","volume":"223","author":"E Pope","year":"2011","unstructured":"Pope E, Doria AS, Theriault M, Mohanta A, Laxer RM (2011) Topical imiquimod 5% cream for pediatric plaque morphea: a prospective, multiple-baseline, open-label pilot study. Dermatology (Basel, Switzerland) 223:363\u2013369","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"3144_CR99","doi-asserted-by":"crossref","unstructured":"Fett N, Werth VP Update on morphea: part II. Outcome measures and treatment. J Am Acad Dermatol 64:231\u2013242 quiz 243\u2013234","DOI":"10.1016\/j.jaad.2010.05.046"},{"key":"3144_CR100","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jaad.2005.11.1063","volume":"54","author":"A Kreuter","year":"2006","unstructured":"Kreuter A, Hyun J, Stucker M, Sommer A, Altmeyer P, Gambichler T (2006) A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol 54:440\u2013447","journal-title":"J Am Acad Dermatol"},{"key":"3144_CR101","unstructured":"Vilela FA, Carneiro S, Ramos-e-Silva M Treatment of morphea or localized scleroderma: review of the literature. J Drugs Dermatol: JDD 9:1213\u20131219"},{"key":"3144_CR102","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/art.30264","volume":"63","author":"F Zulian","year":"2011","unstructured":"Zulian F, Martini G, Vallongo C, Vittadello F, Falcini F, Patrizi A, Alessio M, La Torre F, Podda RA, Gerloni V, Cutrone M, Belloni-Fortina A, Paradisi M, Martino S, Perilongo G (2011) Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 63:1998\u20132006","journal-title":"Arthritis Rheum"},{"key":"3144_CR103","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1365-2133.2006.07497.x","volume":"155","author":"L Weibel","year":"2006","unstructured":"Weibel L, Sampaio MC, Visentin MT, Howell KJ, Woo P, Harper JI (2006) Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children. Br J Dermatol 155:1013\u20131020","journal-title":"Br J Dermatol"},{"key":"3144_CR104","doi-asserted-by":"crossref","unstructured":"Saxton-Daniels S, Jacobe HT An evaluation of long-term outcomes in adults with pediatric-onset morphea. Arch Dermatol 146:1044\u20131045","DOI":"10.1001\/archdermatol.2010.239"},{"key":"3144_CR105","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/rheumatology\/kep244","volume":"48","author":"G Martini","year":"2009","unstructured":"Martini G, Ramanan AV, Falcini F, Girschick H, Goldsmith DP, Zulian F (2009) Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil. Rheumatology (Oxford, England) 48:1410\u20131413","journal-title":"Rheumatology (Oxford, England)"},{"key":"3144_CR106","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2340\/00015555-1136","volume":"91","author":"B Stausbol-Gron","year":"2011","unstructured":"Stausbol-Gron B, Olesen AB, Deleuran B, Deleuran MS (2011) Abatacept is a promising treatment for patients with disseminated morphea profunda: presentation of two cases. Acta Derm Venereol 91:686\u2013688","journal-title":"Acta Derm Venereol"},{"key":"3144_CR107","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1525-1470.2008.00848.x","volume":"26","author":"M Perez Crespo","year":"2009","unstructured":"Perez Crespo M, Betlloch Mas I, Mataix Diaz J, Lucas Costa A, Ballester Nortes I (2009) Rapid response to cyclosporine and maintenance with methotrexate in linear scleroderma in a young girl. Pediatr Dermatol 26:118\u2013120","journal-title":"Pediatr Dermatol"},{"key":"3144_CR108","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/18743129014090100030","volume":"9","author":"ID Ferguson","year":"2015","unstructured":"Ferguson ID, Weiser P, Torok KS (2015) A case report of successful treatment of recalcitrant childhood localized scleroderma with infliximab and leflunomide. Open Rheumatol J 9:30\u201335","journal-title":"Open Rheumatol J"},{"key":"3144_CR109","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00296-011-2126-1","volume":"32","author":"A Heiligenhaus","year":"2012","unstructured":"Heiligenhaus A, Michels H, Schumacher C, Kopp I, Neudorf U, Niehues T, Baus H, Becker M, Bertram B, Dannecker G, Deuter C, Foeldvari I, Frosch M, Ganser G, Gaubitz M, Gerdes G, Horneff G, Illhardt A, Mackensen F, Minden K, Pleyer U, Schneider M, Wagner N, Zierhut M (2012) Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Rheumatol Int 32:1121\u20131133","journal-title":"Rheumatol Int"},{"key":"3144_CR110","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5301\/jsrd.5000259","volume":"2","author":"JA Ivan Foeldvari","year":"2017","unstructured":"Ivan Foeldvari JA, Friswell M, Bica B, de Inocencio J, Aquilani A, Helmus N (2017) Tocilizumab is a promising treatment option for therapy resistant juvenile localized scleroderma patients. J Scleroderma Relat Disord 2:203\u2013207","journal-title":"J Scleroderma Relat Disord"},{"key":"3144_CR111","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/rheumatology\/kep093","volume":"49","author":"D Daoussis","year":"2010","unstructured":"Daoussis D, Liossis SN, Tsamandas AC, Kalogeropoulou C, Kazantzi A, Sirinian C, Karampetsou M, Yiannopoulos G, Andonopoulos AP (2010) Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study. Rheumatology (Oxford, England) 49:271\u2013280","journal-title":"Rheumatology (Oxford, England)"},{"key":"3144_CR112","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.pcl.2012.03.011","volume":"59","author":"KS Torok","year":"2012","unstructured":"Torok KS (2012) Pediatric scleroderma: systemic or localized forms. Pediatr Clin N Am 59:381\u2013405","journal-title":"Pediatr Clin N Am"},{"key":"3144_CR113","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.3899\/jrheum.100062","volume":"37","author":"ML Palmero","year":"2010","unstructured":"Palmero ML, Uziel Y, Laxer RM, Forrest CR, Pope E (2010) En coup de sabre scleroderma and Parry\u2013Romberg syndrome in adolescents: surgical options and patient-related outcomes. J Rheumatol 37:2174\u20132179","journal-title":"J Rheumatol"},{"key":"3144_CR114","doi-asserted-by":"publisher","first-page":"e660","DOI":"10.1097\/GOX.0000000000000621","volume":"4","author":"N Sautereau","year":"2016","unstructured":"Sautereau N, Daumas A, Truillet R, Jouve E, Magalon J, Veran J, Casanova D, Frances Y, Magalon G, Granel B (2016) Efficacy of autologous microfat graft on facial handicap in systemic sclerosis patients. Plastic Reconstr Surg Global Open 4:e660","journal-title":"Plastic Reconstr Surg Global Open"},{"key":"3144_CR115","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.3727\/096368915X687552","volume":"24","author":"J Magalon","year":"2015","unstructured":"Magalon J, Daumas A, Veran J, Magalon G, Rossi P, Granel B, Sabatier F (2015) Autologous adipose tissue-derived cells: are we talking about adipose derived stem cells, stromal vascular fraction, or Coleman fat grafting? Cell Transplant 24:2667\u20132668","journal-title":"Cell Transplant"},{"key":"3144_CR116","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.clim.2011.10.003","volume":"142","author":"G Dueckers","year":"2012","unstructured":"Dueckers G, Guellac N, Arbogast M, Dannecker G, Foeldvari I, Frosch M, Ganser G, Heiligenhaus A, Horneff G, Illhardt A, Kopp I, Krauspe R, Markus B, Michels H, Schneider M, Singendonk W, Sitter H, Spamer M, Wagner N, Niehues T (2012) Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis. Clin Immunol 142:176\u2013193","journal-title":"Clin Immunol"},{"key":"3144_CR117","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jaad.2012.03.036","volume":"67","author":"F Zulian","year":"2012","unstructured":"Zulian F, Vallongo C, Patrizi A, Belloni-Fortina A, Cutrone M, Alessio M, Martino S, Gerloni V, Vittadello F, Martini G (2012) A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea). J Am Acad Dermatol 67:1151\u20131156","journal-title":"J Am Acad Dermatol"},{"key":"3144_CR118","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/rheumatology\/41.10.1178","volume":"41","author":"G Martini","year":"2002","unstructured":"Martini G, Murray KJ, Howell KJ, Harper J, Atherton D, Woo P, Zulian F, Black CM (2002) Juvenile-onset localized scleroderma activity detection by infrared thermography. Rheumatology (Oxford, England) 41:1178\u20131182","journal-title":"Rheumatology (Oxford, England)"},{"key":"3144_CR119","doi-asserted-by":"crossref","unstructured":"Adeeb F, Anjum S, Hodnett P, Kashif A, Brady M, Morrissey S, Devlin J, Fraser AD (2017) Early- and late-stage morphea subtypes with deep tissue involvement is treatable with abatacept (Orencia). Semin Arthritis Rheum 46:775\u2013781","DOI":"10.1016\/j.semarthrit.2016.08.018"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-018-3144-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-018-3144-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-018-3144-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T14:13:38Z","timestamp":1720275218000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-018-3144-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":119,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["3144"],"URL":"https:\/\/doi.org\/10.1007\/s00431-018-3144-8","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]},"assertion":[{"value":"26 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"no confidential data were used regarding this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}